Expression of LR11, a mosaic LDL receptor family member, is markedly increased in atherosclerotic lesions

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 19, Issue 11, 1999, Pages 2687-2695

  Kanaki, Tatsuro ^a   Bujo, Hideaki ^a   Hirayama, Satoshi ^a,b   Ishii, Itsuko ^a   Morisaki, Nobuhiro ^a   Schneider, Wolfgang Johann ^b   Saito, Yasushi ^a  

^a CHIBA UNIVERSITY   (Japan)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

Atherosclerosis; LDL receptor; Smooth muscle cell; THP 1

Indexed keywords

LOW DENSITY LIPOPROTEIN RECEPTOR;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTERY ENDOTHELIUM; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CHOLESTEROL DIET; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FAMILY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0032749335     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.19.11.2687     Document Type: Article

References (49)

1. Ylä-Herttuala S. Expression of lipoprotein receptors and related molecules in atherosclerotic lesions. Curr Opin Lipidol. 1996;7:292-297.
2. Yamamoto T, Bujo H. Close encounters with apolipoprotein E receptors. Curr Opin Lipidol. 1996;7:298-302.
3. Schneider WJ, Nimpf J, Bujo H. Novel members of the LDL receptor superfamily and their potential roles in lipid metabolism. Curr Opin Lipidol. 1997;8:315-319.
4. Hajjar DP, Haberland ME. Lipoprotein trafficking in vascular cells: molecular Trojan horses and cellular saboteurs. J Biol Chem. 1997;272:22975-22978.
5. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801-809.
6. Luoma JS, Hiltunen TP, Särkioja T, Moestrup SK, Gliemann J, Kodama T, Nikkari T, Ylä-Herttuala S. Expression of alpha2-macroglobulin receptor/low density lipoprotein receptor-related protein and scavenger receptor in human atherosclerotic lesions. J Clin Invest. 1994;93:2014-2021.
7. Wyne KL, Pathak PK, Seabra MC, Hobbs HH. Expression of the VLDL receptor in endothelial cells. Arterioscler Thromb Vasc Biol. 1996;16:407-415.
8. Nakazato K, Ishibashi T, Shindo J, Shiomi M, Maruyama Y. Expression of very low density lipoprotein receptor mRNA in rabbit atherosclerotic lesions. Am J Pathol. 1996;149:1831-1838.
9. Multhaupt HAB, Gåfvals ME, Kariko K, Jin H, Arenas-Elliot C, Goldman BI, Straus JF III, Angelin B, Warhol MJ, McCrae KR. Expression of very low density lipoprotein receptor in the vascular wall: analysis of human tissues by in situ hybridization and immunochemistry. Am J Pathol. 1996;148:1985-1997.
10. Hiltunen TP, Luoma JS, Nikkari T, Ylä-Herttuala S. Expression of LDL receptor, VLDL receptor, LDL receptor-related protein, and scavenger receptor in rabbit atherosclerotic lesions: marked induction of scavenger receptor and VLDL receptor expression during lesion development. Circulation. 1998;97:1079-1086.
11. Suzuki J, Takahashi S, Oida K, Shimada A, Kohno M, Tamai T, Miyabo S, Yamamoto T, Nakai T. Lipid accumulation and foam cell formation in Chinese hamster ovary cells overexpressing very low density lipoprotein receptor. Biochem Biophys Res Commun. 1995;206:835-842.
12. Krieger M, Herz J. Structures and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL receptor-related protein (LRP). Annu Rev Biochem. 1994;63:601-637.
13. 2-macroglobulin receptor and epithelial glycoprotein-330: two giant receptors mediating endocytosis of multiple ligands. Biochim Biophys Acta. 1994;1197:197-213.
14. Schneider WJ. Yolk precursor transport in the laying hen. Curr Opin Lipidol. 1995;6:92-96.
15. Strickland DK, Kounnas MZ, Argraves WS. LDL receptor-related protein: a multifunctional receptor for lipoprotein and proteinase catabolism. FASEB J. 1995;9:890-898.
16. Ishikawa Y, Akasaka Y, Ishii T, Komiyama K, Masuda S, Asuwa N, Choi-Miura NH, Tomita M. Distribution and synthesis of apolipoprotein J in the atherosclerotic aorta. Arterioscler Thromb Vasc Biol. 1998;18:665-672.
17. Yamazaki H, Bujo H, Kusunoki J, Seimiya K, Kanaki T, Morisaki N, Schneider WJ, Saito Y. Elements of neural adhesion molecules and a yeast vacuolar protein sorting receptor are present in a novel mammalian low density lipoprotein receptor family member. J Biol Chem. 1996;271:24761-24768.
18. Moerwald S, Yamazaki H, Bujo H, Kusunoki J, Kanaki T, Seimiya K, Morisaki N, Nimpf J, Schneider WJ, Saito Y. A novel mosaic protein containing LDL receptor elements is highly conserved in humans and chickens. Arterioscler Thromb Vasc Biol. 1997;17:996-1002.
19. Bujo H, Lindstedt KA, Hermann M, Dalmau LM, Nimpf J, Schneider WJ. Chicken oocytes and somatic cells express different splice variants of a multifunctional receptor. J Biol Chem. 1995;270:23546-23551.
20. Marcusson EG, Horazdovsky BF, Cereghino JL, Gharakhanian E, Emr SD. The sorting receptor for yeast vacuolar carboxypeptidase is encoded by the VPS10 gene. Cell. 1994;77:579-586.
21. 2-macroglobulin receptor associated protein (RAP). J Biol Chem. 1996;271:31379-31383.
22. Kanaki T, Bujo H, Hirayama S, Tanaka K, Yamazaki H, Seimiya K, Morisaki N, Schneider WJ, Saito Y. Developmental regulation of LR11 expression in murine brain. DNA Cell Biol. 1998;17:647-657.
23. Hermans-Borgmeyer I, Hampe W, Schinke B, Methner A, Nykjaer A, Suesens U, Fenger U, Herbarth B, Schaller HC. Unique expression pattern of a novel mosaic receptor in the developing cerebral cortex. Mech Dev. 1998;70:65-76.
24. Ueno H, Haruno A, Morisaki N, Furuya M, Kangawa K, Takeshita A, Saito Y. Local expression of C-type natriuretic peptide markedly suppresses neointimal formation in rat injured arteries through an autocrine/paracrine loop. Circulation. 1997;96:2272-2279.
25. Bujo H, Hermann M, Kaderli MO, Jacobsen L, Sugawara S, Nimpf J, Yamamoto T, Schneider WJ. Chicken oocyte growth is mediated by an eight ligand binding repeat member of the LDL receptor family. EMBO J. 1994;13:5165-5175.
26. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual. Plainview, NY: Cold Spring Harbor Laboratory Press; 1989.
27. Tamura K, Kanaoka Y, Jinno S, Nagata A, Ogiso Y, Shimizu K, Hayakawa T, Nojima H, Okayama H. Cyclin G: a new mammalian cyclin with homology to fission yeast Cig1. Oncogene. 1993;8:2113-2118.
28. Hasel KW, Glass JR, Godbout M, Sutcliffe JG. An endoplasmic reticulum-specific cyclophilin. Mol Cell Biol. 1991;11:3484-3491.
29. Takahashi K, Jiang XC, Sakai N, Yamashita S, Hirano K, Bujo H, Yamazaki H, Kusunoki J, Miura T, Kussie P, Matsuzawa Y, Saito Y, Tall A. A missense mutation in the cholesteryl ester transfer protein gene with possible dominant effects on plasma high density lipoproteins. J Clin Invest. 1993;92:2060-2064.
30. Ross R. The pathogenesis of atherosclerosis: an update. N Engl J Med. 1976;314:488-500.
31. Wei GL, Krasinski K, Kearney M, Isner JM, Walsh K, Andrés V. Temporally and spatially coordinated expression of cell cycle regulatory factors after angioplasty. Circ Res. 1997;80:418-426.
32. van Leuwen RT. Extracellular proteolysis and migrating vascular smooth muscle cell. Fibrinolysis. 1996;10:59-74.
33. Godyna S, Liau G, Popa I, Stefansson S, Argraves WS. Identification of the low density lipoprotein receptor-related protein (LRP) as an endocytic receptor for thrombospondin-1. J Cell Biol. 1995;129:1403-1410.
34. Kounnas MZ, Loukinova EB, Stefansson S, Harmony JAK, Brewer BH, Strickland DK, Argraves WS. Identification of glycoprotein 330 as an endocytic receptor for apolipoprotein J/clusterin. J Biol Chem. 1995;270:13070-13075.
35. 2-macroglobulin receptor mediates the cellular internalization and degradation of thrombospondin. J Biol Chem. 1995;270:9543-9549.
36. Franke I, Buck F, Hampe W. Purification of a head-activator receptor from hydra. Eur J Biochem. 1997;244:940-945.
37. Quach TT, Duchemin AM, Oliver AP, Schrier BK, Wyatt RJ. Hydra head activator peptide has trophic activity for eukaryotic neurons. Brain Res Dev Brain Res. 1992;68:97-102.
38. Niemann S, Schaller HC. Head-activator and the neuroectodermal differentiation of P19 mouse embryonal carcinoma cells. Neurosci Lett. 1996;207:49-52.
39. Weaver AM, Hussaini IM, Mazar A, Henkin J, Gonias SL. Embryonic fibroblasts that are genetically deficient in low density lipoprotein receptor-related protein demonstrate increased activity of the urokinase receptor system and accelerated migration on vitronectin. J Biol Chem. 1997;272:14372-14379.
40. 2-macroglobulin receptor in invasive cell clones derived from human prostate and breast tumor cells. Oncol Res. 1994;6:365-372.
41. 2-niacroglobulin receptor and its receptor-associated protein in late stages of cutaneous melanocytic tumor progression. Cancer Res. 1996;56:1432-1439.
42. 2-macroglobulin receptor/low density lipoprotein receptor related protein is increased in reactive and neoplastic glial cells. FEBS Lett. 1994;338:301-305.
43. 2-macroglobulin receptor in human malignant astrocytomas. Cancer Res. 1997;57:2799-2805.
44. 2-macroglobulin receptor/low density lipoprotein receptor-related protein is cell culture density-dependent in human breast cancer cell line BT-20. Biochem Biophys Res Commun. 1997;240:122-127.
45. Orlandi O, Ehrlich HP, Ropraz P, Spagnoli LG, Gabbiani G. Rat aortic smooth muscle cells isolated from different layers and at different times after endothelial denudation show distinct biological features in vitro. Arterioscler Thromb. 1994;14:982-989.
46. Bochaton-Piallat ML, Gabbiani G, Pepper MS. Plasminogen activator expression in rat arterial smooth muscle cells depends on their phenotype and is modulated by cytokines. Circ Res. 1998;82:1086-1093.
47. Rennick RE, Campbell JH, Campbell GR. Vascular smooth muscle cell phenotype and growth behaviour can be influenced by macrophages in vitro. Atherosclerosis. 1988;71:35-43.
48. Campbell JH, Rennick RE, Kalevitch SG, Campbell GR. Heparan sulfate-degrading enzymes induce modulation of smooth muscle phenotype. Exp Cell Res. 1992;200:156-167.
49. Raines EW, Ross R. Multiple growth factors are associated with lesions of atherosclerosis: specificity or redundancy? Bioessays. 1995;18:271-282.